10.03.26 -- Clinical Supply Leader Best Of September

Unused clinical trial supplies present complex logistical and compliance challenges. Learn why returns, reconciliation, and forecasting matter after a study ends.

Clinical supply failures often start long before a stockout, when CMC, quality, regulatory, and clinical decisions create risks that supply teams inherit too late.

Clinical Supply Leader unveils its first Editorial Advisory Board, featuring leaders across clinical supply, quality, regulatory affairs, technology, and strategy.

This playbook from Collaborative Sourcing's Matthew Holt and Graham Phillipson gives pharma executives a cross-functional framework for selecting CDMOs and API manufacturers that won't fail.

Flexible clinical development requires scalable infrastructure, strong project management, and global logistics to ensure supply continuity and regulatory compliance.

Plan clinical trials in China by aligning with NMPA requirements and leveraging Free Trade Zones to streamline approvals and clinical supply imports.